Product Description
Suhagra is a pharmaceutical formulation containing Sildenafil citrate as its active component. This potent therapeutic agent is primarily indicated for the management of erectile dysfunction (ED) in male patients. Manufactured by Cipla Ltd., a globally renowned pharmaceutical corporation, this medication adheres to stringent quality standards.
Primary Indications
Suhagra is clinically prescribed for the treatment of erectile dysfunction, a prevalent male sexual health condition characterized by the inability to achieve or sustain an erection sufficient for satisfactory sexual performance.
Administration Guidelines
For optimal results, Suhagra should be administered approximately one hour prior to anticipated sexual activity. The therapeutic window ranges from 30 minutes to 4 hours before intercourse. While the medication can be taken with or without food, consumption alongside high-fat meals may potentially delay its onset of action.
Mechanism of Action
Suhagra exerts its pharmacological effect by inducing relaxation of the smooth musculature in the penile vasculature, thereby enhancing blood circulation to the corpus cavernosum. This physiological response facilitates erection development upon sexual stimulation. It is crucial to note that the medication requires sexual arousal to produce its intended effect.
Therapeutic Advantages
Suhagra provides an evidence-based therapeutic approach for erectile dysfunction management. By improving penile blood flow, it enables patients to attain and maintain erections, thereby enhancing sexual performance and overall sexual satisfaction.
Adverse Effects
As with all pharmacological agents, Suhagra may produce certain adverse reactions. Commonly reported effects include cephalalgia (headache), vertigo, visual disturbances, gastrointestinal discomfort, facial flushing, and cutaneous eruptions. These symptoms are typically transient and self-limiting. Persistent or severe reactions warrant immediate medical consultation.
Dosage Protocol
The standard therapeutic regimen consists of a single oral tablet administered as needed, approximately one hour prior to sexual activity. The maximum recommended dosing frequency is once per 24-hour period. Strict adherence to healthcare provider instructions is imperative.
Precautions and Contraindications
Suhagra is contraindicated in female patients, individuals below 18 years of age, patients with severe cardiovascular or hepatic impairment, those with recent cerebrovascular or myocardial infarction events, and individuals with known hypersensitivity to Sildenafil citrate. Medical consultation is mandatory prior to therapy initiation.
Storage Conditions
Maintain Suhagra at controlled room temperature (15-30°C/59-86°F). Protect from light and moisture exposure. Avoid storage in humid environments such as bathrooms. Keep securely out of reach of children and domestic animals.
Reviews
There are no reviews yet